Insider Activity of 10X Fund, L.P.
According to the SEC Form 4 filings, 10X Fund, L.P., being in a position of
- 10 percent owner at Galectin Therapeutics Inc.,оver the last 12 months, has bought 0 shares, and sold 232750 shares for $1.34M,over all time since 2013-10-07, has bought 0 shares, and sold 1734318 shares for $12.84M.
Biography of 10X Fund, L.P.
No biography is available at this moment.